Press release
11.11.2022 To the attention of interested persons EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors […]
Press release
11.11.2022 To the attention of interested persons EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines download document …
Press release
10.11.2022 To the attention of interested persons EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine download […]
Important notification
09.11.2022 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Important notification
09.11.2022 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Important notification
07.11.2022 To the attention of authorised representatives, manufacturers, economic operators and all stakeholders Please be informed that on 31 October […]
Important notification
31.10.2022 To the attention of manufacturers of in vitro diagnostic medical devices, economic operators, notified bodies and all stakeholders Please […]
Press release
28.10.2022 To the attention of interested persons EMA recommends measures to minimise risk of serious side effects with Janus kinase […]
Press release
28.10.2022 To the attention of interested persons EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines download document …
Important notification
14.10.2022 To the attention of medical devices manufacturers and all stakeholders On 13.10.2022, Emergency ordinance regarding the setup of an […]